MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2024-03-30, TEST had $119.5M increase in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
$119.5M

Unit: Million (M) dollars (except for numbers of shares and EPS)
Cash Flow
2024-03-30
Net earnings
269.6
Depreciation
18.2
Amortization of other intangible assets
6.3
Provision for losses on finance receivables
18.2
Provision for losses on non-finance receivables
4.9
Stock-based compensation expense
9.8
Deferred income tax provision (benefit)
1.6
Gain on sales of assets
0.2
Trade and other accounts receivable
47.9
Contract receivables
4
Inventories
-22.1
Prepaid expenses and other current assets
3.5
Accounts payable
23.3
Accrued and other liabilities
30.3
Net cash provided by operating activities
348.7
Additions to finance receivables
248
Collections of finance receivables
207.8
Capital expenditures
21.8
Disposals of property and equipment
1.1
Other
2.3
Net cash used by investing activities
-63.2
Net increase (decrease) in other short-term borrowings
-0.4
Cash dividends paid
98.2
Purchases of treasury stock
70.2
Proceeds from stock purchase plan and stock option exercises
28.3
Other
-23.7
Net cash used by financing activities
-164.2
Effect of exchange rate changes on cash and cash equivalents
-1.8
Increase in cash and cash equivalents
119.5
Cash and cash equivalents at beginning of period
1,001.5
Cash and cash equivalents at end of period
1,121
Unit: Million (M) dollars

Time Plot

Show the time plot by selecting a row from the table.

null (TEST)

null (TEST)